The cybersecurity software developer increased its overall funding to $43m in a Zscaler-backed series B round.

The kidney healthcare provider boosted its total funding to more than $220m in a round led by Alphabet's CapitalG subsidiary.

Tencent and Gilead Sciences took part in a round that will fund clinical trials for three of Vaccitech's vaccine product candidates.

Novo co-led an $81.5m round for the gene therapy developer that included Sarepta Therapeutics, UCB Ventures, Takeda Ventures and Alexandria Venture Investments.

UF Innovate Ventures has contributed to a series B round for StrideBio, partially based on research into gene therapies at University of Florida.

The spinout’s technology was fundamental to Oxford’s covid vaccine, prompting OSI and Future Planet Capital to back a $168m round.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

RA Capital Management and Rock Springs Capital have co-led a series B round for the gene editing technology developer spun out of Stanford six months ago.

GV and Salesforce Ventures joined existing investor Citi in a $45m round for the financial application development platform.

Xiaomi-backed smart electronics provider Longcheer received $100m in a round co-led by Shenzhen Capital Group and Shenzhen Qianhai Wanrong Hongtu Investment Fund.